GDNF and alcohol use disorder

Addict Biol. 2019 May;24(3):335-343. doi: 10.1111/adb.12628. Epub 2018 May 4.

Abstract

Glial cell line-derived neurotrophic factor (GDNF) has been extensively studied for its role in the development and maintenance of the midbrain dopaminergic system, although evidence suggests that GDNF also plays a role in drug and alcohol addiction. This review focuses on the unique actions of GDNF in the mechanisms that prevent the transition from recreational alcohol use to abuse. Specifically, we describe studies in rodents suggesting that alcohol acutely increases GDNF expression in the ventral tegmental area, which enables the activation of the mitogen-activated protein kinase signaling pathway and the gating of alcohol intake. We further provide evidence to suggest that GDNF acts in the ventral tegmental area via both nongenomic and genomic mechanisms to suppress alcohol consumption. In addition, we describe findings indicating that when this endogenous protective pathway becomes dysregulated, alcohol intake levels escalate. Finally, we describe the potential use of GDNF inducers as a novel therapeutic approach to treat alcohol use disorder.

Keywords: GDNF; addiction; alcohol; ethanol; mesolimbic system; nucleus accumbens; ventral tegmental area.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alcoholism / etiology*
  • Alcoholism / physiopathology
  • Central Nervous System Depressants / pharmacology
  • Dopaminergic Neurons / physiology
  • Ethanol / pharmacology
  • Glial Cell Line-Derived Neurotrophic Factor / physiology*
  • Humans
  • Limbic System / pathology
  • Mental Disorders / etiology
  • Mental Disorders / physiopathology
  • Nucleus Accumbens / physiology
  • Signal Transduction / physiology
  • Tegmentum Mesencephali / physiology

Substances

  • Central Nervous System Depressants
  • Glial Cell Line-Derived Neurotrophic Factor
  • Ethanol